Surveillance guidelines based on recurrence patterns for upper tract urothelial carcinoma

被引:8
|
作者
Locke, Jennifer A. [1 ]
Hamidizadeh, Reza [1 ]
Kassouf, Wassim [2 ]
Rendon, Ricardo A. [3 ]
Bell, David [3 ]
Izawa, Jonathan [4 ]
Chin, Joseph [4 ]
Kapoor, Anil [5 ]
Shayegen, Bobby [5 ]
Lattouf, Jean-Baptiste [6 ]
Saad, Fred [6 ]
Lacombe, Louis [7 ]
Fradet, Yves [7 ]
Fairey, Adrien S. [8 ]
Jacobson, Niels-Eric [8 ]
Drachenberg, Darrel E. [9 ]
Cagiannos, Ilias [10 ]
So, Alan I. [1 ]
Black, Peter C. [1 ]
机构
[1] Univ British Columbia, Vancouver, BC, Canada
[2] McGill Univ, Montreal, PQ, Canada
[3] Dalhousie Univ, Halifax, NS, Canada
[4] Univ Western Ontario, London, ON, Canada
[5] McMaster Univ, Hamilton, ON, Canada
[6] Univ Montreal, Montreal, PQ, Canada
[7] Laval Univ, Quebec City, PQ, Canada
[8] Univ Alberta, Edmonton, AB, Canada
[9] Univ Manitoba, Winnipeg, MB, Canada
[10] Univ Ottawa, Ottawa, ON, Canada
来源
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2018年 / 12卷 / 08期
关键词
RADICAL NEPHROURETERECTOMY; TUMOR LOCATION; BLADDER-TUMORS; IMPACT; SURVIVAL; OUTCOMES; MULTIFOCALITY; ASSOCIATION;
D O I
10.5489/cuaj.5377
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Upper tract urothelial carcinoma (UTUC) accounts for 5% of all urothelial tumours. Due to its rarity, evidence regarding postoperative surveillance is lacking. The objective of this study was to develop a post-radical nephroureterectomy (RNU) surveillance protocol based on recurrence patterns in a large, multi-institutional cohort of patients. Methods: Retrospective clinical and pathological data were collected from 1029 patients undergoing RNU over a 15-year period (1994-2009) at 10 Canadian academic institutions. A multivariable model was used to identify prognostic clinicopathological factors, which were then used to define risk categories. Risk-based surveillance guidelines were proposed based on actual recurrence patterns. Results: Overall, 555 (49.9%) patients developed recurrence, including 289 (25.9%) in the urothelium and 266 (23.9%) with loco-regional and distant recurrences. Based on multivariable analysis, three risk groups were identified: 1) low-risk patients with pTa-T1, pN0 disease, and no adverse histological features (high tumour grade, lymphovascular invasion [LVI], tumour multifocality); 2) intermediate-risk patients with pTa-T1, pN0 disease with one or more of the adverse histological features; and 3) high-risk patients with a >= pT2 tumour and/or nodal involvement. Low-, intermediate-, and high-risk patients were free of urothelial recurrence at three years in 72%, 66%, and 63%, respectively, and free of regional/distant recurrence in 93%, 87%, and 62%, respectively. The risks of loco-regional and distant recurrences (p<0.0001) and time to death (p<0.0001) were significantly different between the low-, intermediate-, and high-risk patients. Conclusions: Based on recurrence patterns in a large, multicentre patient cohort, we have proposed an evidence-based, risk-adapted post-RNU surveillance protocol.
引用
收藏
页码:243 / 251
页数:9
相关论文
共 50 条
  • [1] European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
    Roupret, Morgan
    Babjuk, Marko
    Comperat, Eva
    Zigeuner, Richard
    Sylvester, Richard J.
    Burger, Maximilian
    Cowan, Nigel C.
    Boehle, Andreas
    Van Rhijn, Bas W. G.
    Kaasinen, Eero
    Palou, Joan
    Shariat, Shahrokh F.
    EUROPEAN UROLOGY, 2015, 68 (05) : 868 - 879
  • [2] Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence for upper tract urothelial carcinoma after radical nephroureterectomy
    Yu, Tsung Yu
    Wang, Hung Jen
    Sung, Min Tse
    Chuang, Yao Chi
    Chen, Yen Ta
    Cheng, Yuan Tso
    Kang, Chih Hsiung
    Liu, Hui Ying
    Chang, Yin Lun
    Luo, Hao Lun
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (04) : 410 - 418
  • [3] Bladder tumor recurrence after urothelial carcinoma of the upper urinary tract
    Lonergan, Peter E.
    Porten, Sima P.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (04) : 1891 - 1896
  • [4] Effectiveness of adjuvant radiotherapy for high recurrence risk patients with upper tract urothelial carcinoma
    Li, Xiaoying
    Li, Hongzhen
    Gao, Xian-Shu
    Fang, Dong
    Qin, Shangbin
    Zhang, Zheng
    Zhou, Liqun
    Li, Xuesong
    Wang, Dian
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (09) : 410.e1 - 410.e10
  • [5] Gold standard nephroureterectomy, chemoprophylaxis and surveillance in upper tract urothelial carcinoma
    Basile, Giuseppe
    Bandini, Marco
    Li, Roger
    Poch, Michael A.
    Necchi, Andrea
    Spiess, Philippe E.
    CURRENT OPINION IN UROLOGY, 2025, 35 (01) : 75 - 82
  • [6] European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update
    Roupret, Morgan
    Babjuk, Marko
    Comperat, Eva
    Zigeuner, Richard
    Sylvester, Richard J.
    Burger, Maximilian
    Cowan, Nigel C.
    Gontero, Paolo
    Van Rhijn, Bas W. G.
    Mostafid, A. Hugh
    Palou, Joan
    Shariat, Shahrokh F.
    EUROPEAN UROLOGY, 2018, 73 (01) : 111 - 122
  • [7] Prognostic Impact of Preoperative Anemia on Urothelial and Extraurothelial Recurrence in Patients With Upper Tract Urothelial Carcinoma
    Milojevic, Bogomir
    Dzamic, Zoran
    Kajmakovic, Boris
    Durutovic, Otas
    Bumbasirevic, Uros
    Grujicic, Sandra Sipetic
    CLINICAL GENITOURINARY CANCER, 2015, 13 (05) : 485 - 491
  • [8] Patterns of Recurrence in Upper Tract Transitional Cell Carcinoma: Imaging Surveillance
    Mao, Yun
    Kilcoyne, Aoife
    Hedgire, Sandeep
    Preston, Mark A.
    McGovern, Francis J.
    Dahl, Douglas M.
    Harisinghani, Mukesh
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2016, 207 (04) : 789 - 796
  • [9] Risk factors for intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma
    Yamashita, Ryo
    Watanabe, Reiko
    Ito, Ichiro
    Shinsaka, Hideo
    Nakamura, Masafumi
    Matsuzaki, Masato
    Niwakawa, Masashi
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (03) : 425 - 430
  • [10] Oncologic surveillance intensity after endoscopic treatment of upper tract urothelial carcinoma
    Basile, Giuseppe
    Gallioli, Andrea
    Martini, Alberto
    Verri, Paolo
    Robalino, Jorge
    Dieguez, Lucia
    Gavrilov, Pavel
    Territo, Angelo
    Uleri, Alessandro
    Gaya, Josep M.
    Algaba, Ferran
    Palou, Joan
    Breda, Alberto
    MINERVA UROLOGY AND NEPHROLOGY, 2024, 76 (01): : 88 - 96